Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Corsini

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Oncotarget|April 28, 2015
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancersArianna Giacomini, Sara Matarazzo, Katiuscia Pagano, et al.
Angiogenesis|October 15, 2017
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factorsImtiaz M Nawaz, Paola Chiodelli, Sara Rezzola, et al.
European Journal of Cell Biology|October 8, 2024
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cellsElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlinMichela Corsini, Emanuela Moroni, Cosetta Ravelli, et al.
Angiogenesis|August 1, 2019
VEGFR2 activation mediates the pro-angiogenic activity of BMP4Sara Rezzola, Margherita Di Somma, Michela Corsini, et al.
Biochimica Et Biophysica Acta. General Subjects|October 1, 2023
The D647N mutation of FGFR1 induces ligand-independent receptor activationMattia Domenichini, Cosetta Ravelli, Michela Corsini, et al.
Molecular Cancer Therapeutics|October 14, 2010
Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1Roberto Ronca, Patrizia Benzoni, Daria Leali, et al.
Cell Death & Disease|January 14, 2026
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodelingMichela Corsini, Cosetta Ravelli, Mattia Domenichini, et al.
Oncotarget|May 14, 2016
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonistElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Cancers|June 2, 2021
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma CellsRoberto Ronca, Sara Taranto, Michela Corsini, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Oncotarget|April 28, 2015
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancersArianna Giacomini, Sara Matarazzo, Katiuscia Pagano, et al.
Angiogenesis|October 15, 2017
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factorsImtiaz M Nawaz, Paola Chiodelli, Sara Rezzola, et al.
European Journal of Cell Biology|October 8, 2024
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cellsElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlinMichela Corsini, Emanuela Moroni, Cosetta Ravelli, et al.
Angiogenesis|August 1, 2019
VEGFR2 activation mediates the pro-angiogenic activity of BMP4Sara Rezzola, Margherita Di Somma, Michela Corsini, et al.
Biochimica Et Biophysica Acta. General Subjects|October 1, 2023
The D647N mutation of FGFR1 induces ligand-independent receptor activationMattia Domenichini, Cosetta Ravelli, Michela Corsini, et al.
Molecular Cancer Therapeutics|October 14, 2010
Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1Roberto Ronca, Patrizia Benzoni, Daria Leali, et al.
Cell Death & Disease|January 14, 2026
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodelingMichela Corsini, Cosetta Ravelli, Mattia Domenichini, et al.
Oncotarget|May 14, 2016
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonistElisabetta Grillo, Cosetta Ravelli, Michela Corsini, et al.
Cancers|June 2, 2021
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma CellsRoberto Ronca, Sara Taranto, Michela Corsini, et al.
Pageof 6